Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals, Inc

Amplyx Pharmaceuticals is developing novel, broadspectrum antifungal agents for the treatment of lifethreatening invasive fungal infections due to candida, aspergillus and rare molds..
Type
B2b
Founded
2006
Raised
$128.7M
Follow us
Alexa global traffic share
19 May 2020
$53,000,000
Venture capital (Series C)

Amplyx Pharmaceuticals Closes $53M Series C Extension

FinSMEs
+1
01 Aug 2017
$67,000,000
Venture capital (Series C)

Antifungal biotech Amplyx Pharmaceuticals raises $67 million

The San Diego Union-Tribune
+1